WARNING: This product is for research use only, not for human or veterinary use.
Fenazinel Dihydrochloride, also known as SIPI-5052, is a N-methyl-D-aspartate (NMDA) receptor antagonist potentially for the treatment of ischemic stroke.
Price and Availability
Fenazinel dihydrochloride (SIPI-5052) is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to firstname.lastname@example.org to inquire quote.
MedKoo Cat#: 527509
Name: Fenazinel Dihydrochloride
Chemical Formula: C21H27Cl2N3O2
Molecular Weight: 424.366
Elemental Analysis: C, 59.44; H, 6.41; Cl, 16.71; N, 9.90; O, 7.54
Related CAS #:
685138-02-7 (HCl); 685137-46-6 (SIPI-5052)
Fenazinel dihydrochloride; SIPI-5052; SIPI 5052; SIPI5052
>98% (or refer to the Certificate of Analysis)
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Soluble in DMSO
>2 years if stored properly
This drug may be formulated in DMSO
Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
Harmonized System Code: